Literature DB >> 20673303

Treatment of vitiligo in children and adolescents by autologous cultured pure melanocytes transplantation with comparison of efficacy to results in adults.

W S Hong1, D N Hu, G P Qian, S A McCormick, A E Xu.   

Abstract

BACKGROUND: Transplantation of autologous cultured pure melanocytes is a well-established procedure for the treatment of refractory and stabilized vitiligo. However, there was no report specifically comparing the efficacy with the regard to defined age groups (children-adolescence-adult).
OBJECTIVE: We analysed the efficacy of this procedure in the treatment of vitiligo in children and adolescents and compare it with the results in adults treated during the same period and using identical procedures.
METHODS: Melanocytes were isolated from the roof of suction blister, cultured and expanded with Hu16 medium in vitro, and transplanted to laser-denuded receipt area. A total of 12 children (8-12 years), 20 adolescents (13-17 years) and 70 adults with vitiligo were treated using this procedure.
RESULTS: The patients obtained satisfactory results (repigmentation of 50% or more) results in children, adolescents and adults were 83.3%, 95.0% and 84.0% respectively. The mean extent of repigmentation in children, adolescents and adults was 80.7%, 78.9% and 76.6% respectively. There was no statistical difference in repigmentation among these three groups. After adjusting for all factors (gender, type of vitiligo, period of stability, location of the lesion or transplanted cell density) individually or totally using multiple regression analysis, age still did not correlate to the extent of repigmentation.
CONCLUSIONS: The satisfactory results obtained in the treatment of vitiligo in children and adolescents by transplantation of cultured autologous pure melanocytes are comparable with the results in adults. Therefore, this procedure can be considered in refractory and stable vitiligo in children and adolescents, especially in patients with large vitiliginous lesions.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 20673303     DOI: 10.1111/j.1468-3083.2010.03824.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  9 in total

1.  Evaluation of Repigmentation with Cultured Melanocyte Transplantation (CMT) Compared with Non-Cultured Epidermal Cell Transplantation in Vitiligo at 12th Week Reveals Better Repigmentation with CMT.

Authors:  Gunjan Verma; Suraj R Varkhande; Hemanta K Kar; Rajni Rani
Journal:  J Invest Dermatol       Date:  2015-05-07       Impact factor: 8.551

2.  Efficacy of suction blister epidermal grafting with concomitant phototherapy in vitiligo treatment.

Authors:  Tomasz Iwanowski; Piotr Szlązak; Alicja Rustowska; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2018-11-08       Impact factor: 1.837

Review 3.  Cultured Epidermal Melanocyte Transplantation in Vitiligo: A Review Article.

Authors:  Shaghayegh Zokaei; Dariush D Farhud; Mohammad Keykhaei; Marjan Zarif Yeganeh; Hoda Rahimi; Hamideh Moravvej
Journal:  Iran J Public Health       Date:  2019-03       Impact factor: 1.429

4.  Inhibition of Fam114A1 protects melanocytes from apoptosis through higher RACK1 expression.

Authors:  Miaoni Zhou; Fuquan Lin; Xingang Wu; Zhuyi Ping; Wen Xu; Rong Jin; Aie Xu
Journal:  Aging (Albany NY)       Date:  2021-11-27       Impact factor: 5.682

5.  Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.

Authors:  V S Narayan; L L C van den Bol; N van Geel; M W Bekkenk; R M Luiten; A Wolkerstorfer
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02-12       Impact factor: 6.166

6.  Efficacy of suction blister epidermal graft without phototherapy for locally stable and resistant vitiligo.

Authors:  Masoud Maleki; Mahnaz Banihashemi; Vahid Sanjari
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

7.  Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.

Authors:  Miao-ni Zhou; Zhi-qing Zhang; Ji-long Wu; Fu-quan Lin; Li-fang Fu; Sui-qan Wang; Cui-ping Guan; Hong-lin Wang; Aie Xu
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

8.  CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.

Authors:  Jilong Wu; Miaoni Zhou; Yinsheng Wan; Aie Xu
Journal:  Mol Med Rep       Date:  2012-10-08       Impact factor: 2.952

9.  CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation.

Authors:  Fuquan Lin; Wenting Hu; Wen Xu; Miaoni Zhou; Ai-E Xu
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.